🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The LBA is beyond excited to share with you our newest member and collaborating partner! Welcome Russell Dahl, CEO of Neurodon Corporation. Learn more about Neurodon: neurodon.net/about/ #CellularStress #CalciumImbalance #SERCA #DiseaseResearch #BreakthroughTherapeutics

Today starts the 11th Annual Aging Research & Drug Discovery (ARDD) Meeting. The event is fully booked, with LBA proudly sponsoring and supporting. Over the next five days, 180+ global experts will discuss advancements in aging, metabolism, neurodegeneration, & related diseases.

Dr. Nir Barzilai sat down with Longevity Technology's (Longevity Technology) Editor-in-Chief, Phil Newman, ahead of the fifth edition of Longevity Investors Conference (Longevity Investors) to discuss advancements in gerotherapeutics and aging research. youtube.com/watch?v=x_wfvb…

The LBA welcomes newest member, Chris Mirabile, Founder & CEO of NOVOS. NOVOS Labs uses science to create nutraceuticals that extend healthspan. Targeting 12 root causes of aging, their formulations deliver synergistic effects beyond standard supplements. novoslabs.com

The LBA introduces Jamie Justice, EVP of Health at XPRIZE, in conversation with James Peyer. They discuss the #XPRIZEHealthspan, its alignment with longevity goals, and opportunities for collaboration, as 431 teams from 53 countries prepare to compete. youtu.be/NXBD3kY2Qjc

Congratulations to Life Biosciences, an LBA partner, for being named a 2024 INNOFIRE Award honoree by BostInno! They're leading the way in cellular rejuvenation therapies to tackle aging and chronic diseases. lifebiosciences.com

LBA member, Dr. Nir Barzilai, was featured on Business Insider's “Explainers” series, where he explored the potential of longevity drugs used in dogs and how these findings could contribute to extending human lifespan by promoting healthier aging. businessinsider.com/longevity-drug…

The LBA welcomes Cellergy Therapeutics and its CEO Rachel Diamant. Cellergy Therapeutics aims to revolutionize human health by harnessing the regenerative power of young mitochondria to energize cells, combat degenerative diseases, and promote longevity. cellergy-bio.com

LBA member Aubrey de Grey (LEV Foundation) presented at the 11th ARDD Meeting. His talk, "Taking Rejuvenation to Longevity Escape Velocity: Combinatorial Rejuvenation in Mice," explored advancements in achieving longevity through rejuvenation strategies. youtube.com/watch?v=EEjsNR…

A study by LBA collaborator, Buck Institute, found that favoring the maternal X chromosome accelerates brain aging and impairs cognition in female mammals. CRISPR reactivation of silenced genes restored memory, revealing potential therapeutic targets. nature.com/articles/s4158…

LBA partner, LyGenesis, reached a major milestone in their Phase 2a clinical trial using allogeneic cell therapy to regenerate liver tissue! They are now enrolling their second patient cohort and escalating the dose as planned. prnewswire.com/news-releases/…

Cellergy Therapeutics, a partner of the LBA, has launched their new website, highlighting their work in producing functional #mitochondria to #restore energy, #combat degenerative diseases, and #promote longevity. To learn more - cellergy-bio.com

Join AFAR for a free webinar on emerging technologies in aging research, featuring experts in #bioprinting and organ #regeneration. Moderated by LBA member Sergey Young. Join AFAR from 12-1pm ET on Thursday, March 20th. Learn more & RSVP here: afar.org/events/webinar…

Vascarta Inc. has released its latest paper, introducing a new approach to #curcumin delivery. Unlike traditional oral administration, this study explores a topical formulation (VASCEPTOR®) designed for more effective absorption. linkedin.com/feed/update/ur…

The LBA co-founder, James Peyer, hosted a roundtable discussion featuring Alex Colville, Managing Partner at age1. They explored how AGE1 is revolutionizing healthcare by investing in science-driven technologies aimed at extending healthspan. youtu.be/mx3Gq0xwB1k

Juvenescence, co-founded by LBA member Jim Mellon, was highlighted by Bloomberg for the new strategic partnership and investment from M42 Health. Learn more - bloomberg.com/news/articles/…

The Academy for Health and Lifespan Research, composed of the world’s leading scientists in aging biology, is committed to advancing the promise of geroscience. The biology of aging is modifiable; it can be altered, slowed, and delayed. To extend healthspan and improve quality of

Six LBA partners will be featured at the A4LI Summit, including Eric Morgen (BioAge), Joe Betts-LaCroix (Retro Biosciences), Aurora Griffin (LongeVC), Chris Bradley (Matter Bio), Michael Ringel (Life Biosciences), & Alexandra Bause (Apollo Health Ventures) a4li.org/dc-summit-2025/

Congratulations to LongeVC (LongeVC), collaborative partner of the LBA, on their portfolio company being selected as a semi-finalist in the XPRIZE Global Healthspan Challenge and a finalist in the SOLVE FSHD Challenge - earning 2x $250,000 in recognition and funding!

The THRIVE Act, co-authored by Dr. Zan Fleming, David Fox, & Thomas Seoh—experts in FDA regulation & biotech—the Act outlines a tiered framework to support healthspan interventions. Offering incentives, such as FDA-led guidance, market exclusivity & more. youtu.be/u8XurK-J848